[go: up one dir, main page]

IL136742A0 - Kappa receptor opioid peptides - Google Patents

Kappa receptor opioid peptides

Info

Publication number
IL136742A0
IL136742A0 IL13674298A IL13674298A IL136742A0 IL 136742 A0 IL136742 A0 IL 136742A0 IL 13674298 A IL13674298 A IL 13674298A IL 13674298 A IL13674298 A IL 13674298A IL 136742 A0 IL136742 A0 IL 136742A0
Authority
IL
Israel
Prior art keywords
opioid peptides
kappa receptor
receptor opioid
kappa
peptides
Prior art date
Application number
IL13674298A
Other languages
English (en)
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of IL136742A0 publication Critical patent/IL136742A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13674298A 1997-12-23 1998-12-22 Kappa receptor opioid peptides IL136742A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/997,208 US5965701A (en) 1997-12-23 1997-12-23 Kappa receptor opioid peptides
PCT/US1998/027282 WO1999032510A1 (fr) 1997-12-23 1998-12-22 Peptides recepteurs opioides kappa

Publications (1)

Publication Number Publication Date
IL136742A0 true IL136742A0 (en) 2001-06-14

Family

ID=25543752

Family Applications (3)

Application Number Title Priority Date Filing Date
IL13674298A IL136742A0 (en) 1997-12-23 1998-12-22 Kappa receptor opioid peptides
IL136742A IL136742A (en) 1997-12-23 2000-06-12 Opaque peptides for kafa receptor and preparations containing them
IL178471A IL178471A0 (en) 1997-12-23 2006-10-05 Kappa receptor opioid peptides and compositions comprising them

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL136742A IL136742A (en) 1997-12-23 2000-06-12 Opaque peptides for kafa receptor and preparations containing them
IL178471A IL178471A0 (en) 1997-12-23 2006-10-05 Kappa receptor opioid peptides and compositions comprising them

Country Status (32)

Country Link
US (1) US5965701A (fr)
EP (1) EP1042359B1 (fr)
JP (1) JP4275852B2 (fr)
KR (1) KR100629548B1 (fr)
CN (1) CN1154655C (fr)
AR (1) AR014167A1 (fr)
AT (1) ATE301670T1 (fr)
AU (1) AU747806B2 (fr)
BR (2) BR9814499B1 (fr)
CA (1) CA2315878C (fr)
CR (1) CR5936A (fr)
CZ (1) CZ297281B6 (fr)
DE (1) DE69831176T2 (fr)
DK (1) DK1042359T3 (fr)
EE (1) EE04440B1 (fr)
ES (1) ES2247735T3 (fr)
HR (1) HRP20000415B1 (fr)
HU (1) HU227640B1 (fr)
IL (3) IL136742A0 (fr)
MY (1) MY117542A (fr)
NO (1) NO327080B1 (fr)
NZ (1) NZ505183A (fr)
PL (1) PL195842B1 (fr)
PT (1) PT1042359E (fr)
RU (1) RU2217437C2 (fr)
SK (1) SK286135B6 (fr)
TR (1) TR200001985T2 (fr)
TW (1) TW580502B (fr)
UA (1) UA68366C2 (fr)
UY (1) UY25327A1 (fr)
WO (1) WO1999032510A1 (fr)
ZA (1) ZA9811801B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
WO2001036006A1 (fr) * 1999-11-19 2001-05-25 Palatin Technologies, Inc. Compositions de metallo-peptides opioides, et methodes associees
DE10116978A1 (de) * 2001-04-05 2002-10-10 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
CA2451133C (fr) * 2001-05-08 2012-09-18 Toray Industries, Inc. Agent therapeutique contre la sepsie
SI1494732T1 (sl) 2002-03-20 2008-08-31 Mannking Corp Inhalacijski aparat
KR101273120B1 (ko) 2004-08-20 2013-06-13 맨카인드 코포레이션 다이케토피페라진 합성의 촉매 작용
BR122019022692B1 (pt) 2004-08-23 2023-01-10 Mannkind Corporation Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
KR101486829B1 (ko) 2005-09-14 2015-01-29 맨카인드 코포레이션 결정질 미립자 표면에 대한 활성제의 친화력의 증가를 기반으로 하는 약물 제제의 방법
EP1986679B1 (fr) 2006-02-22 2017-10-25 MannKind Corporation Procédé pour améliorer les propriétés pharmaceutiques de microparticules comprenant de la dicétopipérazine et un agent actif
WO2007139921A2 (fr) * 2006-05-26 2007-12-06 Cara Therapeutics, Inc. N-oxydes de peptides de récepteurs de kappa-opioïdes
EP2040733A2 (fr) * 2006-05-26 2009-04-01 Cara Therapeutics, Inc. Procédé destiné à élever le taux de prolactine chez des mammifères
US8236766B2 (en) * 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
US7402564B1 (en) * 2006-11-10 2008-07-22 Cara Therapeutics, Inc. Synthetic peptide amides
US7842662B2 (en) * 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US8906859B2 (en) * 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US7713937B2 (en) * 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
WO2008077194A1 (fr) * 2006-12-22 2008-07-03 Xenome Ltd Agonistes de récepteurs
TWI677355B (zh) 2008-06-13 2019-11-21 美商曼凱公司 用於藥物傳輸之乾粉吸入器及系統
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2421385T3 (es) 2008-06-20 2013-09-02 Mannkind Corp Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2676695A3 (fr) 2009-03-11 2017-03-01 MannKind Corporation Appareil, système et procédé de mesure de résistance d'un inhalateur
MY186975A (en) 2009-06-12 2021-08-26 Mannkind Corp Diketopiperazine microparticles with defined specific surface areas
US9016147B2 (en) 2009-11-03 2015-04-28 Mannkind Corporation Apparatus and method for simulating inhalation efforts
MX359281B (es) 2010-06-21 2018-09-21 Mannkind Corp Sistema y metodos para suministrar un farmaco en polvo seco.
US8925726B2 (en) 2011-04-01 2015-01-06 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (fr) 2011-06-17 2012-12-20 Mannkind Corporation Microparticules de dicétopipérazine de capacité élevée
CA2852536A1 (fr) * 2011-10-24 2013-05-02 Mannkind Corporation Procedes et compositions pour traiter la douleur
CA2878457C (fr) 2012-07-12 2021-01-19 Mannkind Corporation Systemes et procedes de liberation de medicament en poudre seche
EP2911690A1 (fr) 2012-10-26 2015-09-02 MannKind Corporation Compositions et procédés de vaccin antigrippal inhalable
EP2970149B1 (fr) 2013-03-15 2019-08-21 MannKind Corporation Compositions de dicétopipérazine microcristallines et procédés
EP3021834A1 (fr) 2013-07-18 2016-05-25 MannKind Corporation Compositions pharmaceutiques en poudre sèche stables à la chaleur et procédés
CN105517607A (zh) 2013-08-05 2016-04-20 曼金德公司 吹入设备和方法
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
CN106459150B (zh) * 2014-06-26 2020-01-24 丸石制药株式会社 合成五肽的制造方法
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
JP6651546B2 (ja) * 2015-05-11 2020-02-19 カディラ・ヘルスケア・リミテッド カッパ（κ）オピオイド受容体（ＫＯＲ）アゴニストとしての新規の短鎖ペプチド
CN107098876B (zh) * 2016-02-23 2021-04-06 江苏恒瑞医药股份有限公司 苯基丙酰胺类衍生物、其制备方法及其在医药上的应用
JP6794602B2 (ja) * 2016-09-27 2020-12-02 シチュアン ケルン−バイオテック バイオファーマシューティカル カンパニー リミテッド ポリアミド化合物及びその使用
TWI712615B (zh) * 2017-07-21 2020-12-11 大陸商四川海思科製藥有限公司 肽醯胺類化合物、其製備方法及醫藥用途
KR20200096588A (ko) 2017-12-06 2020-08-12 지앙수 헨그루이 메디슨 컴퍼니 리미티드 페닐프로피온아마이드 유도체의 염 및 이의 제조 방법
TW202015716A (zh) 2018-05-16 2020-05-01 大陸商江蘇恆瑞醫藥股份有限公司 一種ｋｏｒ受體激動劑醫藥組成物
CN114127086B (zh) * 2019-07-25 2023-10-20 四川海思科制药有限公司 氘代肽酰胺类化合物及其制备方法和在医药上的用途
WO2021013085A1 (fr) * 2019-07-25 2021-01-28 四川海思科制药有限公司 Sel d'amide peptidique, son procédé de préparation et son utilisation en médecine
CN114615976A (zh) * 2019-08-07 2022-06-10 人福医药美国公司 κ阿片受体肽酰胺激动剂
CN115884963A (zh) 2020-06-25 2023-03-31 人福医药美国公司 用于治疗医学病症的肽
WO2023278843A2 (fr) 2021-07-02 2023-01-05 Acer Therapeutics, Inc. Formes solides d'osanétant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2013689B (en) * 1977-12-15 1982-03-24 Reckitt & Colmann Prod Ltd Compounds
GB8801304D0 (en) * 1988-01-21 1988-02-17 Ici Plc Diamine compounds
US5367053A (en) * 1993-05-19 1994-11-22 Houghten Pharmaceuticals, Inc. Opioid peptide inhibitors
RU2067000C1 (ru) * 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US5610271A (en) * 1995-06-07 1997-03-11 Torrey Pines Institute For Molecular Studies Kappa receptor selective opioid peptides

Also Published As

Publication number Publication date
HRP20000415B1 (en) 2004-06-30
CZ297281B6 (cs) 2006-10-11
AU1940299A (en) 1999-07-12
KR100629548B1 (ko) 2006-09-27
CZ20002382A3 (cs) 2000-12-13
MY117542A (en) 2004-07-31
RU2217437C2 (ru) 2003-11-27
CN1154655C (zh) 2004-06-23
EE200000370A (et) 2001-10-15
ES2247735T3 (es) 2006-03-01
HRP20000415A2 (en) 2000-12-31
HUP0100626A2 (hu) 2001-08-28
TW580502B (en) 2004-03-21
KR20010033450A (ko) 2001-04-25
US5965701A (en) 1999-10-12
WO1999032510A9 (fr) 1999-09-23
CA2315878C (fr) 2010-11-16
DK1042359T3 (da) 2005-11-28
EP1042359A1 (fr) 2000-10-11
PT1042359E (pt) 2005-11-30
ATE301670T1 (de) 2005-08-15
EE04440B1 (et) 2005-02-15
BR9814499A (pt) 2000-10-10
PL341308A1 (en) 2001-04-09
SK9602000A3 (en) 2001-01-18
NO20003245D0 (no) 2000-06-21
HUP0100626A3 (en) 2001-12-28
EP1042359B1 (fr) 2005-08-10
AU747806B2 (en) 2002-05-23
DE69831176D1 (de) 2005-09-15
BRPI9814499A (pt) 2000-10-10
UY25327A1 (es) 2000-12-29
TR200001985T2 (tr) 2000-11-21
CR5936A (es) 2006-08-18
NO327080B1 (no) 2009-04-20
BRPI9814499B8 (pt) 2021-11-09
PL195842B1 (pl) 2007-10-31
JP4275852B2 (ja) 2009-06-10
AR014167A1 (es) 2001-02-07
CA2315878A1 (fr) 1999-07-01
UA68366C2 (en) 2004-08-16
JP2001526295A (ja) 2001-12-18
NZ505183A (en) 2001-09-28
IL178471A0 (en) 2007-02-11
HK1029349A1 (en) 2001-03-30
SK286135B6 (sk) 2008-04-07
BRPI9814499B1 (pt) 2014-10-21
WO1999032510A1 (fr) 1999-07-01
ZA9811801B (en) 1999-06-22
DE69831176T2 (de) 2006-04-20
BR9814499B1 (pt) 2014-10-21
NO20003245L (no) 2000-08-23
CN1283201A (zh) 2001-02-07
HU227640B1 (en) 2011-10-28
IL136742A (en) 2006-12-31

Similar Documents

Publication Publication Date Title
IL136742A0 (en) Kappa receptor opioid peptides
IL123258A0 (en) Opioid peptides
PL344341A1 (en) Peptides
IL112903A0 (en) GnRH antagonist peptides
EP1007563A4 (fr) Recepteur hm74a
TW345977U (en) Improved structure for nozzle
GB9718110D0 (en) Peptides
HUP0003396A3 (en) Somatostatin antagonist peptides
ZA98256B (en) Tachykinin antagonists
GB9700154D0 (en) Peptides
GB9812675D0 (en) Peptides
IL114046A0 (en) New opioid peptide antagonists
SI1042359T1 (sl) Kappa receptorski opioidni peptidi
GB9827016D0 (en) Receptor protein
IL113441A0 (en) Opioid peptide analoog
GB9807890D0 (en) Peptides
GB2322879B (en) Accomodation unit
ZA983615B (en) Kappa opioid agonists
GB9701024D0 (en) Peptides
GB9706556D0 (en) Peptides
GB9713146D0 (en) Peptides
GB9717431D0 (en) Peptide synthesis
CA81622S (en) Seat cover dispenser
ZA966434B (en) Novel opioid peptides.
GB9719470D0 (en) Nocotinic receptors

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed